Babaoglu, Kerim, Page, Mark A, Jones, Victoria C, McNeil, Michael R, Dong, Changjiang, Naismith, James H and Lee, Richard E (2003) Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis. Bioorganic & Medicinal Chemistry Letters, 13 (19). pp. 3227-3230. ISSN 0960-894X
Full text not available from this repository.Abstract
The emergence of multi-drug resistant tuberculosis, coupled with the increasing overlap of the AIDS and tuberculosis pandemics has brought tuberculosis to the forefront as a major worldwide health concern. In an attempt to find new inhibitors of the enzymes in the essential rhamnose biosynthetic pathway, a virtual library of 2,3,5 trisubstituted-4-thiazolidinones was created. These compounds were then docked into the active site cavity of 6'hydroxyl; dTDP-6-deoxy-D-xylo-4-hexulose 3,5-epimerase (RmlC) from Mycobacterium tuberculosis. The resulting docked conformations were consensus scored and the top 5% were slated for synthesis. Thus far, 94 compounds have been successfully synthesized and initially tested. Of those, 30 (32%) have > or =50% inhibitory activity (at 20 microM) in the coupled rhamnose synthetic assay with seven of the 30 also having modest activity against whole-cell M. tuberculosis.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | binding sites,drug delivery systems,hexosyltransferases,mycobacterium tuberculosis,rhamnose,thiazolidinediones,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Computing Sciences |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology |
Depositing User: | Pure Connector |
Date Deposited: | 17 Nov 2014 12:56 |
Last Modified: | 08 Mar 2024 00:50 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/50994 |
DOI: | 10.1016/S0960-894X(03)00673-5 |
Actions (login required)
View Item |